Our Company
Message from the CEO
Management
Board of Directors
Mission & Strategy
Careers
Open Positions
Online Application
Contact Us
Pipeline
CNS Product Candidates
NP101 - Migraine
Learn more about Migraine
Learn more about MRN
NP201 - Parkinson's Disease
NP202 - Schizophrenia and Bipolar Disorder
Franchise Opportunities
Publications
Proprietary Delivery Technologies
SmartRelief
LAD
Partnering
Strategic Partnering
Partnering Opportunities
Current Collaborations
Investor Relations
Newsroom
Featured News
Press Releases
Media Resources
NuPathe Blog
Innovating Neuroscience
Migraine Resources
Migraine Resources
Careers
Contact Us
Overview
Driving Shareholder Value in NuPathe
The Migraine Market
CEO Q&A
CFO Q&A
Press Releases
Events and Presentations
Corporate Governance
Management
Board of Directors
SEC Filings
Stock Information
Analyst Coverage
Information Request
Annual Reports & Proxy Statements
Investor FAQs
Investor FAQs
I’ve lost my certificate. How do I get a replacement?
For any questions regarding your holdings, please contact our transfer agent:
Broadridge Corporate Issuer Solutions
1717 Arch St.
Philadelphia, PA 19103
(800) 733-1121
shareholder@broadridge.com
www.shareholder.broadridge.com
How do I get news updates from NuPathe?
For news updates, please
sign up here
.
How do I obtain SEC regulatory filings for NuPathe?
For SEC filings, please
sign up here
.
How many shares are outstanding?
NuPathe common stock is traded under the NASDAQ ticker PATH. Details of Common stock outstanding are available
here
.
related
links
NuPathe Blog
CEO Q&A
CFO Q&A
The Migraine Market
Driving Shareholder Value